Literature DB >> 17917041

Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity.

Steven M Holland1.   

Abstract

Susceptibility to mycobacterial infection has long been associated with defects in T cell immunity, such as those conferred by HIV infection or iatrogenic immune suppression. However, despite these well-recognized predispositions to clinical disease with tuberculosis and nontuberculous mycobacteria, the genetic disorders that are relatively specific for mycobacterial infection with nontuberculous bacteria and bacille Calmette Guerin (BCG) involve the innate immune pathways, and all engage interferon gamma and IL-12 production, signaling, and availability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917041     DOI: 10.1007/s12026-007-0045-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  15 in total

1.  Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds.

Authors:  Capucine Picard; Claire Fieschi; Frédéric Altare; Suliman Al-Jumaah; Sami Al-Hajjar; Jacqueline Feinberg; Stéphanie Dupuis; Claire Soudais; Ibrahim Zaid Al-Mohsen; Emmanuelle Génin; David Lammas; Dinakantha S Kumararatne; Tony Leclerc; Arash Rafii; Husn Frayha; Belinda Murugasu; Lee Bee Wah; Raja Sinniah; Michael Loubser; Emi Okamoto; Abdulaziz Al-Ghonaium; Haysam Tufenkeji; Laurent Abel; Jean-Laurent Casanova
Journal:  Am J Hum Genet       Date:  2001-12-17       Impact factor: 11.025

2.  Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.

Authors:  Smita Y Patel; Li Ding; Margaret R Brown; Larry Lantz; Ted Gay; Stuart Cohen; Lenna A Martyak; Bernard Kubak; Steven M Holland
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

3.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.

Authors:  Anne E Hughes; Nick Orr; Hossein Esfandiary; Martha Diaz-Torres; Timothy Goodship; Usha Chakravarthy
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

Review 4.  Interferon-gamma and interleukin-12 pathway defects and human disease.

Authors:  S E Dorman; S M Holland
Journal:  Cytokine Growth Factor Rev       Date:  2000-12       Impact factor: 7.638

5.  Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.

Authors:  U Dirksen; R Nishinakamura; P Groneck; U Hattenhorst; L Nogee; R Murray; S Burdach
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.

Authors:  Calman MacLennan; Claire Fieschi; David A Lammas; Capucine Picard; Susan E Dorman; Ozden Sanal; Jenny M MacLennan; Steven M Holland; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

7.  A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states.

Authors:  Sergio D Rosenzweig; Susan E Dorman; Gulbu Uzel; Stephen Shaw; Amy Scurlock; Margaret R Brown; Rebecca H Buckley; Steven M Holland
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

Review 8.  Host genetic determinants of Neisseria meningitidis infections.

Authors:  M Emonts; J A Hazelzet; R de Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2003-09       Impact factor: 25.071

9.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

10.  Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.

Authors:  Claire Fieschi; Stéphanie Dupuis; Emilie Catherinot; Jacqueline Feinberg; Jacinta Bustamante; Adrien Breiman; Frédéric Altare; Richard Baretto; Françoise Le Deist; Samer Kayal; Hartmut Koch; Darko Richter; Martin Brezina; Guzide Aksu; Phil Wood; Suliman Al-Jumaah; Miquel Raspall; Alberto José Da Silva Duarte; David Tuerlinckx; Jean-Louis Virelizier; Alain Fischer; Andrea Enright; Jutta Bernhöft; Aileen M Cleary; Christiane Vermylen; Carlos Rodriguez-Gallego; Graham Davies; Renate Blütters-Sawatzki; Claire-Anne Siegrist; Mohammad S Ehlayel; Vas Novelli; Walther H Haas; Jacob Levy; Joachim Freihorst; Sami Al-Hajjar; David Nadal; Dewton De Moraes Vasconcelos; Olle Jeppsson; Necil Kutukculer; Klara Frecerova; Isabel Caragol; David Lammas; Dinakantha S Kumararatne; Laurent Abel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

View more
  24 in total

1.  Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children.

Authors:  N Pavan Kumar; R Anuradha; R Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2011-09-28

2.  Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies.

Authors:  Bich-Thuy T Sim; Sarah K Browne; Marguerite Vigliani; Dalila Zachary; Lindsey Rosen; Steven M Holland; Steven M Opal
Journal:  J Clin Immunol       Date:  2013-05-26       Impact factor: 8.317

3.  The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.

Authors:  Shoba Amarnath; Courtney W Mangus; James C M Wang; Fang Wei; Alice He; Veena Kapoor; Jason E Foley; Paul R Massey; Tania C Felizardo; James L Riley; Bruce L Levine; Carl H June; Jeffrey A Medin; Daniel H Fowler
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

Review 4.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

5.  Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis.

Authors:  Christopher A Duplessis; Drake Tilley; Mary Bavaro; Braden Hale; Steven M Holland
Journal:  J Infect       Date:  2011-07-20       Impact factor: 6.072

6.  Frequency of Mycobacterium bovis and mycobacteria in primary immunodeficiencies.

Authors:  Ezgi Ulusoy; Neslihan Edeer Karaca; Güzide Aksu; Cengiz Çavuşoğlu; Necil Kütükçüler
Journal:  Turk Pediatri Ars       Date:  2017-09-01

7.  IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.

Authors:  Ana I Rovetta; Delfina Peña; Rodrigo E Hernández Del Pino; Gabriela M Recalde; Joaquín Pellegrini; Fabiana Bigi; Rosa M Musella; Domingo J Palmero; Marisa Gutierrez; María I Colombo; Verónica E García
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

8.  An overview of cytokines and cytokine antagonists as therapeutic agents.

Authors:  Raymond P Donnelly; Howard A Young; Amy S Rosenberg
Journal:  Ann N Y Acad Sci       Date:  2009-12       Impact factor: 5.691

9.  Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results.

Authors:  Subash Babu; Sajid Q Bhat; N Pavan Kumar; V Kumaraswami; Thomas B Nutman
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

10.  Familial clustering of pulmonary nontuberculous mycobacterial disease.

Authors:  Rhonda E Colombo; Suvimol C Hill; Reginald J Claypool; Steven M Holland; Kenneth N Olivier
Journal:  Chest       Date:  2009-10-26       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.